Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | COVID-19 pandemic’s impact on the cancer care industry

Angelos M. Stergiou • 20 Oct 2021
General

Angelos M. Stergiou, MD, ScD, SELLAS Life Sciences Group, New York, NY, explores the impact of the COVID-19 pandemic on the cancer care industry, highlighting the effects on the application of standard care for patients, as well as clinical trial enrollment. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Angelos M. Stergiou

9:15
Galinpepimut-S: mechanism of action and use in AML, ovarian cancer & mesothelioma
Angelos M. Stergiou • 20 Oct 2021
1:56
GPS and NPS: novel immunotherapeutics from SELLAS
Angelos M. Stergiou • 20 Oct 2021

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals